Gilbert Schorlemmer, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Orem, UTNPI 1629060553
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. W. L. Gore & Associates, Inc. accounts for 69.3% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $4,579 and has fallen 98.0% since, to $94 in 2025.
Across 102 payments — averaging $62.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$4K
- Novartis$275
- Medtronic$273
- Endologix LLC$242
- Inari Medical, Inc.$211
- Johnson & Johnson$140
- plus $814 from 20 others
Across 4 payments — averaging $874.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$3K
What the payments were for
- Speaking & faculty fees$3,40053%
- Travel & lodging$250%
- Food & beverage$2,94346%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 23 | $4,414 |
| Novartis | 16 | $275 |
| Medtronic(2 entities) | 10 | $273 |
| Endologix LLC | 3 | $242 |
| Inari Medical, Inc. | 6 | $211 |
| Johnson & Johnson(2 entities) | 8 | $140 |
| Pfizer | 5 | $95 |
| Bolton Medical Inc | 1 | $94 |
| Artivion, Inc. | 1 | $88 |
| Amgen | 3 | $80 |
| Boehringer Ingelheim | 4 | $60 |
| Boston Scientific | 1 | $51 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| Merck | 3 | $42 |
| Cardiva Medical, Inc. | 2 | $39 |
| Penumbra, Inc. | 2 | $37 |
| Chiesi USA, Inc. | 1 | $28 |
| Bard Peripheral Vascular, Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Corcym Inc | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $19 |
| Davol Inc. | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $16 |
| Teleflex LLC | 1 | $14 |
| Bayer | 1 | $11 |
| Tactile Systems Technology Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,368 in reported general payments places this provider in the 60th percentile of 46 thoracic surgery (cardiothoracic vascular surgery) providers in Utah.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Orem
- Spencer MelbyOrem$30K
- Brent BowlesSt George$69K
- Jason GlotzbachSalt Lake City$45K
- Charles NeedhamSt George$18K
- John DotyMurray$18K
- Reilly HobbsMurray$15K
- Ganesh KumpatiSalt Lake City$14K
- John StringhamSalt Lake City$14K
- David AffleckSalt Lake City$14K
- Nicolas ContrerasSalt Lake City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.